Sandra Gardiner
Interim Chief Financial OfficeratNektar Therapeutics· In proxies 2023–2025
Sandra Gardiner is CFO of Nektar Therapeutics.
Experience
- Nektar TherapeuticsPublic company · 3 yr
- Interim Chief Financial Officer2023 – Present · 3 yrStock in role +27%
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?